VeraSci

VeraSci VeraSci is a clinical research company that provides clinical software, translation services, and expertise in endpoints and assessments. With scientific expertise, strategic innovation, and unwavering commitment, VeraSci supports each project to help global clients develop novel therapies. Founded in 2004, VeraSci brings scientific expertise, strategic innovation, and steadfast dedication to every project, assisting global clients in the development of new treatments. As global clinical trials become increasingly complex, we believe that well-designed, scientifically driven processes and technologies are the best solution to address sluggish timelines and noisy data. VeraSci's eCOA platform, Pathway, can be easily configured to meet the needs of multinational studies of any size. VeraSci’s experience spans all stages of development, from single Phase I clinical studies to global Phase III clinical trials involving hundreds of raters and thousands of patients. VeraSci provides consulting, site screening, rater training and certification, translation, and data services for over 150 clinical trials across more than 40 countries. Through our commitment to data integrity, our work not only supports the scientific research of new therapies, but also drives significant improvements in the overall quality of clinical trials, enhancing research capabilities to transform healthcare worldwide.